[Effect of omega-3 supplementation on preeclampsia in high risk pregnant women]
Journal of Qazvin University of Medical Sciences [The]. 2011; 15 (2): 28-33
in Persian
| IMEMR
| ID: emr-110439
ABSTRACT
Identification of factors preventing preeclampsia in high risk pregnant women is of prime importance. The omega-3 supplementation may reduce the risk of preeclampsia. The aim of the present study was to assess the effects of omega-3 supplementation on high risk pregnancy for preeclampsia in the city of Qazvin. This was a single-blind randomized clinical trial conducted on 100 high risk pregnant women for preeclampsia over a period between 14 to 18 weeks of gestation in the city of Qazvin, Iran. Fifty patients were assigned to omega-3 group and another 50 to placebo group. Women were given a daily supplementation of 1000mg omega-3 or placebo until delivery. Later, preeclampsia and pregnancy outcome were assessed in both groups. Data were analyzed statistically using t-test, chi square test, Mannwhitney, and Fisher exact tests. There were significant differences between the omega-3 and placebo groups regarding the rate [p=0.015] and intensity [p=0.01] of preeclampsia. Statistically, a significant correlation between the omega-3 group and outcome of pregnancy including the birth weight [p=0.000] and apgar score [p=0.002] was found. Our results suggest that supplementation with omega-3 during pregnancy reduces the risk of preeclampsia in high risk pregnant women. Thus it seems necessary to promote educational programs on nutrition for pregnant women
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Placebos
/
Pre-Eclampsia
/
Pregnancy
/
Single-Blind Method
/
Pregnancy, High-Risk
Type of study:
Controlled clinical trial
Limits:
Female
/
Humans
Language:
Persian
Journal:
J. Qazvin Univ. Med. Sci.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS